Method and device for high-throughput solution exchange for cell and particle suspensions
10967296 · 2021-04-06
Assignee
Inventors
- Dino Di Carlo (Los Angeles, CA)
- Daniel R. Gossett (Los Angeles, CA)
- Henry T. K. Tse (San Francisco, CA)
Cpc classification
B01L2200/0652
PERFORMING OPERATIONS; TRANSPORTING
B01L2400/0487
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502776
PERFORMING OPERATIONS; TRANSPORTING
B01D12/00
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0816
PERFORMING OPERATIONS; TRANSPORTING
B01L2400/084
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502761
PERFORMING OPERATIONS; TRANSPORTING
International classification
B01D12/00
PERFORMING OPERATIONS; TRANSPORTING
Abstract
A method of exchanging fluids with suspended particles includes providing a microfluidic device with a first inlet channel operatively coupled to a source of particles and a second inlet channel operatively coupled to an exchange fluid. A transfer channel is connected at a proximal end to the first inlet channel and the second inlet channel. First and second outlet channels are connected to a distal end of the transfer channel. The source of particles is flowed at a first flow rate into the first inlet channel while the exchange fluid is flowed at a second flow rate into the second inlet channel wherein the ratio of the second flow rate to the first flow rate is at least 1.5. Particles are collected in one of the first and second outlet channels while fluid substantially free of particles is collected in the other of the first and second outlet channels.
Claims
1. A method of transferring particles across fluid streamlines comprising: providing a microfluidic device comprising a plurality of proximal channels and a plurality of distal channels connected to a transfer channel disposed between the plurality of proximal channels and the plurality of distal channels, wherein at least one of the proximal channels is operatively coupled to a source of fluid containing particles suspended therein, at least one of the proximal channels is operatively coupled to a source of exchange fluid; flowing the fluid containing the particles in the at least one proximal channel operatively coupled to the source of fluid containing particles suspended therein; flowing the exchange fluid into the at least one proximal channel operatively coupled to the source of exchange fluid, wherein a co-flow state of the fluid containing the particles suspended therein and the exchange fluid is maintained along substantially all of the transfer channel, wherein at least some of the particles of the fluid containing the particles suspended therein migrate in response to inertial lift forces toward an equilibrium position (X.sub.eq) located within the transfer channel to become migrated particles; transferring the migrated particles into at least one of the plurality of distal channels.
2. The method of claim 1, wherein the particles comprise cells.
3. The method of claim 1, wherein the particles comprise red blood cells.
4. The method of claim 1, wherein the particles comprise white blood cells.
5. The method of claim 1, wherein the fluid containing the particles comprises blood.
6. The method of claim 1, wherein the exchange fluid occupies a larger volume of the transfer channel as compared to the fluid containing the particles.
7. The method of claim 1, further comprising analyzing the particles transferred into one of the plurality of distal channels with an analyzer selected from the group consisting of a flow cytometer, fluorescent-activated cell sorter (FACS), and imager.
8. The method of claim 1, wherein the transfer channel comprises an aspect ratio (height/width) that is <1 and has a length of greater than 1 cm.
9. The method of claim 1, further comprising directing fluid substantially free of particles into at least one of the plurality of distal channels.
10. A method of transferring particles across fluid streamlines comprising: providing a microfluidic device comprising a plurality of solution exchange stages, wherein at least two of the plurality of solution exchange stages comprise a transfer channel having an output channel coupled to an input channel of a downstream transfer channel of a solution exchange downstream stage; flowing a fluid containing the particles suspended therein into the plurality of solution exchange stages; flowing an exchange fluid into the plurality of solution exchange stages, wherein the particles migrate toward an equilibrium position (X.sub.eq) located within respective transfer channels and become migrated particles, wherein inertial lift forces in the respective transfer channels direct the particles toward the equilibrium position (X.sub.eq); directing the migrated particles into one outlet channel in the microfluidic device; and directing fluid substantially free of the migrated particles into one or more other outlet channels in the microfluidic device.
11. The method of claim 10, wherein the particles comprise cells.
12. The method of claim 10, wherein the particles comprise red blood cells.
13. The method of claim 10, wherein the particles comprise white blood cells.
14. The method of claim 10, wherein the fluid containing the particles comprises blood.
15. The method of claim 10, wherein the exchange fluid occupies a larger volume of the transfer channels as compared to the fluid containing the particles.
16. The method of claim 10, wherein a Particle Reynolds number for the migrated particles in the transfer channels is between about 0.25 and about 1.87.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS
(13)
(14) Still referring to
(15) Still referring to
(16) Still referring to
(17) In one aspect of the invention, the flow rate at which the particles 14 suspended in the fluid 16 are flowed into the first inlet channel 12 is different than the flow rate at which the exchange fluid 30 is flowed into the second inlet channel 28. In this regard, the exchange fluid 30 should be flowed into the second inlet channel 28 at a flow rate that exceeds the flow rate of the particles 14 suspended in fluid 16. More particularly, it has been found that the ratio of the flow rate of the exchange fluid 30 to the flow rate of the particles 14 suspended in fluid 16 should be at least about 1.5. In another aspect of the invention, the ratio is within the range of about 1.5 to about 2.0. Typically, the flow rate for the particles 14 suspended in fluid 16 may be in the range of about 50 μl/min. to about 80 μl/min. The flow rate for the exchange fluid 30 may be in the range of about 90 μl/min. to about 120 μl/min although flow rates outside this range may also be used. Generally, the microfluidic device 10 should be constructed such that a Particle Reynolds Number (R.sub.p) is between the range of about 0.25 to about 1.87. R.sub.p is defined as follows:
R.sub.p=ρUa.sup.2/μH (Eq. 1)
(18) where ρ is the density, U is the maximum channel velocity, a is the particle diameter, μ is the viscosity, and H is the channel height. Moreover, the Reynolds number of the fluid flowing through the first inlet channel 12 and the second inlet channel 28 should be less than about 2,000 so as to maintain laminar and not turbulent flow.
(19) The flow rate is high such that an interface 42 is formed between the fluid 16 containing the particles 14 and the exchange fluid 30. This interface 42 is advantageously maintained along substantially the entire length of the transfer channel 36. In this regard, a co-flow state is maintained between the exchange fluid 30 and the fluid 16 containing the particles 14 which is maintained throughout the length of the transfer channel 36. Maintenance of this interface 42 and the establishment of the co-flow state means that there is very little diffusion across this interface. The Peclet number (ratio of convection to diffusion) is typically high (e.g., ˜160,000) such that diffusion across the interface 42 is negligible. Of course, the invention is not limited to a particular Peclet number.
(20) Still referring to
(21) As stated above, the equilibrium position (X.sub.eq) in the transfer channel 36 lies within the exchange fluid 30. Particles 14 are thus pushed by inertial lift forces from the suspension fluid 16 of the co-flow and into the exchange fluid 30 of the co-flow. The particles 14 after reaching the equilibrium position (X.sub.eq) are completely within the exchange fluid 30. The particles 14 are thus exchanged from the original suspension fluid 16 to the exchange fluid 30. The particles 14 continue to travel downstream toward the junction of the plurality of outlet channels 44, 46. In the embodiment of
(22)
(23) The outlet channels 44, 46 are coupled to respective outlet chambers 50, 52 in
(24) One benefit of the microfluidic system 10 described herein is that cells 14 can quickly be interrogated. In the embodiment of
(25) The microfluidic system 10 may be used for many different applications. One primary application of the rapid solution exchange approach disclosed herein is sample preparation. The primary tasks in sample preparation include labeling of cells with targets such as antibodies which are then washed to remove un-bound antibodies. For example, cells could be incubated with antibody then run through the microfluidic system 10 which then transfers labeled cells to a clean solution. These cells could then be analyzed using an inline fluorescence detection system such as that illustrated in
(26) As seen in
(27) TABLE-US-00001 TABLE 1 Channel Relative background fluorescence per 100 μm.sup.2 Inlet 1.00 Reject (RBCs) 0.89 Collect (WBCs) 0.30
(28) The microfluidic system 10 can also be used in histological staining applications as illustrated in
(29)
(30) Another application of the microfluidic device 2 is that particles 14 may be used in conjunction with solution exchange to sequester or elute targets of interest. For example, particles 14 with sizes such that they are subject the same to inertial forces (e.g., the size of cells) may have surfaces functionalized that bind to molecules of interest (e.g., targets). The particles 14 can then be used to bind with the target species and collected while the unwanted molecules can be removed via a waste stream. The reverse could also be employed. For example, previously washed particles 14 having bound targets thereon could be brought into a solution where the molecules elute from the particles 14. The particles 14 could then be capture in a “waste” stream while the other outlet channel(s) can be used to collect the eluted molecules.
(31) One of the advantages of the microfluidic system 10 is that solution exchange happens very quickly (e.g., a couple milliseconds). This allows one to measure dynamic events as they occur in the millisecond time scale. If one had to do this with pipetting or a slow microfluidic method only events in the second or minute time scale would be accessible. Further, the contents of the solutions are not the only important factors. One could have two solutions with different pH or temperatures. These solutions could be used to elute bound molecules, as mentioned above, test the response of materials to these conditions, or bring biosamples into a temperature required for a specific event to occur, like nucleic acid denaturation, annealing, or amplification.
(32)
(33) The second transfer channel 72 has a proximal end 71 that starts at the junction of the outlet channel 44 and the third inlet channel 74 and a distal end 73 that terminates at third outlet channel 82 and fourth outlet channel 84. The particles 14 that enter the second transfer channel 72 from the outlet 44 migrate in a similar manner as described herein to the second exchange fluid 76. The particles 14 remain therein and travel downstream to the third outlet channel 82 while non-particulate matter (e.g., debris, impurities) can then be shunted to the fourth outlet channel 84 and into chamber 86. In this embodiment, there is double-solution exchange in a very short period of time. For example, as one example, the first stage of solution exchange (with exchange fluid 30) may include a wash or clean-up while the second stage of solution exchange (with second exchange fluid 76) may include a lysing agent. In this example, the nucleus may then be collected in one of the downstream collection channels 82, 84. As another example, the first stage of solution exchange (with exchange fluid 30) may include a wash or clean-up while the second stage of solution exchange (with second exchange fluid 76) may include a dye. This embodiment is particularly suited for sample preparation where multiple steps are used. Not only can the microfluidic device 10, 70 be used for immunohistochemistry or selective lysis, it can also be used for transfection, fixation, and permeabilization.
(34)
(35) The microfluidic system 90 includes a second inlet 104 that is connected an inlet channel 106. The second inlet 104 is operatively coupled to an exchange fluid (not shown) that is similar to the other embodiments described herein. Namely, the second inlet 104 is connected to a pump such as a syringe pump or the like that is configured to exchange fluid through the second inlet 104 and into the inlet channel 106. The second inlet 104 may include filters 108 downstream thereof which trap large debris and aggregates similar to those described with respect to other filters. The focusing regions 100, 102 intersect with the inlet channel 106 at the beginning of transfer channel 110. Transfer channel 110 extends for at least 1 cm and terminates at three outlet channels 112, 114, 116. There is a central outlet channel 112 that is configured to collect particles in the exchange solution. The two outer outlet channels 114, 116 are configured to collect waste solution (e.g., fluid suspending particles). The central outlet channel 112 may be coupled to a collection chamber 118 or, alternatively, the central outlet channel 112 may continue onward to additional downstream processing such as an analyzer as described herein. The two outer outlet channels 114, 116 may be connected to a common collection chamber 120 as is illustrated in
(36)
(37) The microfluidic systems 10, 70, 90 may be manufactured using processes commonly known to those skilled in the art to make microfluidic devices. For example, the microfluidic system 10, 70, 90 may be designed using software such as AutoCAD (Autodesk, San Rafael, Calif., USA). Transparency photomasks for these designs can be printed at 20,000 dots per inch (CAD/Art Services, Inc., Bandon, Oreg., USA). Molds for replica molding can then be prepared using these masks. Negative photoresist, SU-8 50 (MicroChem, Newton, Mass., USA) is spun on a four (4) inch Silicon wafer at 4,000 rotations per minute. The coated wafer is then soft baked at 65° C. for 5 minutes then 95° C. for 15 minutes. The wafer is then exposed under near UV at 8.0 mW/cm.sup.2 for 30 seconds. A post-exposure bake of the wafer can be carried out at 65° C. for 2 minutes then at 95° C. for 3.5 minutes. The unexposed photoresist is then developed in SU-8 Developer (MicroChem) until an isopropyl alcohol rinse produced no white film. The height of the resulting features can be characterized by a surface profiler.
(38) The width of microchannels immediately before and after the extensional flow region was 67 μm. The height of the features in the device was 28 μm. The mold is then taped to the lower plate of a petri dish with features facing up and an approximately 6 mm layer of Sylgard 184 Silicone Elastomer (Dow Corning, Midland, Mich., USA), polydimethylsiloxane (PDMS), mixed 10 parts base to 1 part curing agent, is poured on top. The cast mold is then placed in a vacuum chamber and the chamber was evacuated for 30 minutes to remove air from the curing polymer. It was then moved to an oven set to 65° C. for 3 hours. The devices were cut from the mold and inlet and outlets were punched into the cured polymer. They were then placed in a plasma cleaner along with slide glasses to be activated. After a 30 second exposure to air plasma the activated surfaces of PDMS and glass were placed in contact to form permanent covalent bonds between the two materials. While a PDMS-based construction is described herein it should be understood that the system and methods disclosed herein are not so limited. Other microfluidic manufacturing methods may be employed.
(39) The microfluidic systems 10, 70, 90 discussed herein offer the ability for high-throughput processing of particles 14 for solution exchange. For example, the microfluidic systems 10, 70, 90 are able to achieve throughputs in excess of 1,000 particles 14 per second. Further, various aspects of the different embodiments described herein may be substituted with one another. As an example, the downstream analyzer 62 may be used with any of the embodiments described herein. Thus, while several embodiments have been described herein it should be appreciated that various aspects or elements are interchangeable with other separate embodiments.
(40) While embodiments have been shown and described, various modifications may be made without departing from the scope of the inventive concepts disclosed herein. The invention(s), therefore, should not be limited, except to the following claims, and their equivalents.